Clinical Trials Logo

Clinical Trial Summary

During coronary artery bypass surgery, myocardial protection, especially of the right ventricle, may be inadequate in the presence of severe coronary lesions that obstruct the antegrade delivery of cold cardioplegia


Clinical Trial Description

Asymetric myocardial cooling has been reported to yield postoperative right ventricular dysfunction, which may contribute to postoperative morbidity and mortality. Retrograde coronary sinus perfusion was introduced in 1956 to facilitate surgery involving the aortic valve. This technique was introduced as a means of myocardial protection for coronary artery bypass surgery in 1967 and has recently received renewed interest. An innovative method of delivering retrograde cardioplegia through the right atrium was recently developed by Fabiani and associates. This technique has obviated the need to directly cannulate the coronary sinus and thus has eliminated concerns regarding coronary sinus rupture due to cannulation, and concerns of inadequate right ventricular perfusion. In contrast to antegrade delivery, retrograde delivery of cardioplegia through the right atrium is not subject to the problem of limited distribution in the presence of coronary artery occlusive disease and thus allows more uniform cooling of the left ventricle,so the study will compare the results of combined antegrade and retrograde versurs antegrade cardioplegia in complex coronary artery bypass surgeries ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04439162
Study type Interventional
Source Assiut University
Contact Elhussein M abdelmottaleb, Ph.D
Phone 00201003873076
Email sahs_romeo90@hotmail.com
Status Not yet recruiting
Phase N/A
Start date July 1, 2020
Completion date April 1, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04531007 - Imaging and Physiology for Intermediate Left Main Stem Stenosis N/A
Recruiting NCT05829889 - Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease Phase 4